Disclosure Panels Details Page
Breast Cancer Risk Reduction Panel - Disclosures as of 09/06/2022
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Gretchen Ahrendt MD | None | None | None | None | ✔ |
| Banu Arun MD | AbbVie, Inc. AstraZeneca Pharmaceuticals LP |
None | None | None | - |
| Mary Anne Bergman | None | None | None | None | ✔ |
| Therese Bevers MD | Namida Lab Preferred Medicine Toray International |
None | None | None | ✔ |
| Marian Birkeland PhD | None | None | None | None | - |
| Graham Colditz MD, DrPH, FAFPHM | Centene Corp , St Louis Grailbio |
None | None | None | ✔ |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | ✔ |
| Laura Fejerman PhD, MSc | None | None | None | None | ✔ |
| Carla Fisher MD | None | None | None | None | ✔ |
| Shipra Gandhi MD | Alkermes Athenex Roswell Park |
None | None | None | ✔ |
| Mary Gemignani MD | None | None | None | None | - |
| Heidi Goodwin APRN, CNP | None | None | None | None | ✔ |
| William Gradishar MD | Daiichi- Sankyo Co. Genentech, Inc. Novartis Pharmaceuticals Corporation Seattle Genetics, Inc. |
ambrx AstraZeneca Pharmaceuticals LP Merck & Co., Inc. Pfizer Inc. |
None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | ✔ |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Shelley Hwang MD, MPH | Lumicell | AstraZeneca Pharmaceuticals LP Merck & Co., Inc. |
Merck & Co., Inc. Pfizer Inc. |
None | - |
| Lisa Jacobs MD | None | None | None | None | ✔ |
| Judith Jordan BS | None | None | None | AbbVie, Inc.|Pfizer Inc. | ✔ |
| Tari King MD | None | expert testimony Genomic Health, Inc. |
Genomic Health, Inc. | None | - |
| Rashmi Kumar PhD | None | None | None | None | ✔ |
| Allison Kurian MD, MSc | Ambry Genetics Myriad Genetic Laboratories, Inc. |
None | None | None | ✔ |
| Sayeh Lavasani MD, MSc, FRCPC | Seattle Genetics, Inc. | None | Seattle Genetics, Inc. | None | ✔ |
| Loretta Loftus MD, MBA | None | None | None | Amgen Inc. |Eli Lilly and Company|Gilead Sciences, Inc.|Johnson & Johnson|Pfizer Inc. | ✔ |
| Aashini Master DO | None | Puma Biotechnology | None | None | ✔ |
| Sofia Merajver MD, PhD | None | None | None | Founder and equity interest in InheRET, Inc. I do not believe that any change in the guidelines would benefit or harm the commercial potential of InheRET, Inc. | - |
| Ingrid Meszoely MD | None | None | None | None | ✔ |
| Rita Mukhtar MD | Agendia BV | Lobular Breast Cancer Alliance Spouse does expert witness work in general surgery cases (various but not related to breast cancer) |
None | None | ✔ |
| Catherine Parker MD | None | None | None | None | ✔ |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Frances Pritchard MD | None | None | None | None | - |
| Sandhya Pruthi MD | None | None | None | None | ✔ |
| Asal Rahimi MD | Accuray Incorporated | Hologic Kaleido- husband participation Mallinckrodt- husband participation Valiance - husband participation |
Accuray Incorporated GE Health Hologic |
None | ✔ |
| Sagar Sardesai MD, MPH | None | AstraZeneca Pharmaceuticals LP Gilead Sciences, Inc. |
Biotheranostics Novartis Pharmaceuticals Corporation |
None | ✔ |
| Payal Shah MD | None | None | None | None | ✔ |
| Michelle Specht MD, FACS | None | None | None | None | ✔ |
| Pavan Kumar Tandra MD | None | None | None | None | ✔ |
| Anne Wallace MD, FACS | None | None | None | None | ✔ |
| Lee Wilke MD, FACS | Perimeter medical | None | None | Elucent Medical | ✔ |
| Rachel Yung MD | None | None | None | None | ✔ |